This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB06970/identifier/pdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB06970/identifier/pubchem-compound/
n8http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB06970/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB06970/identifier/drugbank/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/ontology/drugbank/
n5http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB06970/identifier/chemspider/

Statements

Subject Item
n2:DB06970
rdf:type
n4:Drug
n4:group
experimental
owl:sameAs
n7:DB06970 n8:DB06970
dcterms:title
2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE
adms:identifier
n10:99443441 n11:2LG n12:1117937 n13:951886 n14:DB06970
n4:IUPAC-Name
n5:271B63DF-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B63E5-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B63E4-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B63E1-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B63E2-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B63E3-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B63DD-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B63DB-363D-11E5-9242-09173F13E4C5 n5:271B63DE-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B63DC-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B63EB-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B63EC-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B63E6-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B63E7-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B63E9-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B63E8-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B63EA-363D-11E5-9242-09173F13E4C5
n4:Bioavailability
n5:271B63F1-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B63F3-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B63F4-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B63F0-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B63EF-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B63F2-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B63E0-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B63ED-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B63EE-363D-11E5-9242-09173F13E4C5